The table below shows Harmony Biosciences Holdings, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$868.45M
$714.73M
$582.02M
$437.86M
$305.44M
$159.74M
Cost of revenue
$198.34M
$156.81M
$121.24M
$83.48M
$55.52M
$27.74M
Gross profit
$670.11M
$557.92M
$460.79M
$354.37M
$249.92M
$132.00M
R&D
$189.59M
$145.82M
$76.06M
$70.89M
$30.37M
$19.45M
HRMY annual revenue (10-K history)
Harmony Biosciences Holdings, Inc. reported annual revenue of $868.45M for fiscal year 2025. That is up 21.5% from $714.73M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $6.00M (FY 2019) to $868.45M. Figures come from the company's audited annual reports as filed with the SEC.